On June 2, 2022, the Board of Directors of Myriad Genetics, Inc. designated Natalie Munk, the Company's Chief Accounting Officer, to serve as the Company's principal accounting officer. Ms. Munk will assume responsibility as principal accounting officer from R. Bryan Riggsbee, who will continue his role as the Company's Chief Financial Officer and principal financial officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.6 USD | -0.24% | -2.57% | +28.53% |
May. 13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.53% | 2.23B | |
-4.57% | 12.32B | |
-4.35% | 8.1B | |
+8.91% | 5.87B | |
+30.81% | 5.52B | |
-7.42% | 4.29B | |
-54.27% | 3.16B | |
+14.44% | 2.72B | |
-2.21% | 2.37B | |
-4.67% | 1.87B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics, Inc. Announces Executive Changes